A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

E Ellebaek; R B Holmstrom; C H Ruhlmann; H Schmidt; C A Haslund; M Donia; A von Heymann; C Johansen; L Bastholt; I M Svane

doi:10.1016/j.annonc.2021.08.1456

A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

E Ellebaek, R B Holmstrom, C H Ruhlmann, H Schmidt, C A Haslund, M Donia, A von Heymann, C Johansen, L Bastholt, I M Svane

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	1071P
Tidsskrift	Annals of Oncology
Vol/bind	32
Udgave nummer	Suppl. 5
Sider (fra-til)	S889-S889
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2021.08.1456
Status	Udgivet - 2021
Begivenhed	ESMO Congress 2021 - Virtual conference Varighed: 16 sep. 2021 → 21 sep. 2021 https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme

Konference

Konference	ESMO Congress 2021
Lokation	Virtual conference
Periode	16/09/2021 → 21/09/2021
Internetadresse	https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme

Adgang til dokumentet

10.1016/j.annonc.2021.08.1456

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Ellebaek, E., Holmstrom, R. B., Ruhlmann, C. H., Schmidt, H., Haslund, C. A., Donia, M., von Heymann, A., Johansen, C., Bastholt, L., & Svane, I. M. (2021). A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients. Annals of Oncology, 32(Suppl. 5), S889-S889. Artikel 1071P. https://doi.org/10.1016/j.annonc.2021.08.1456

@article{6e09f4f4e38641abb0bc2c02c776f886,

title = "A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients",

author = "E Ellebaek and Holmstrom, {R B} and Ruhlmann, {C H} and H Schmidt and Haslund, {C A} and M Donia and {von Heymann}, A and C Johansen and L Bastholt and Svane, {I M}",

year = "2021",

doi = "10.1016/j.annonc.2021.08.1456",

language = "English",

volume = "32",

pages = "S889--S889",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 5",

note = "ESMO Congress 2021 ; Conference date: 16-09-2021 Through 21-09-2021",

url = "https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme",

}

Ellebaek, E, Holmstrom, RB, Ruhlmann, CH, Schmidt, H, Haslund, CA, Donia, M, von Heymann, A, Johansen, C, Bastholt, L & Svane, IM 2021, 'A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients', Annals of Oncology, bind 32, nr. Suppl. 5, 1071P, s. S889-S889. https://doi.org/10.1016/j.annonc.2021.08.1456

TY - ABST

T1 - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

AU - Ellebaek, E

AU - Holmstrom, R B

AU - Ruhlmann, C H

AU - Schmidt, H

AU - Haslund, C A

AU - Donia, M

AU - von Heymann, A

AU - Johansen, C

AU - Bastholt, L

AU - Svane, I M

PY - 2021

Y1 - 2021

U2 - 10.1016/j.annonc.2021.08.1456

DO - 10.1016/j.annonc.2021.08.1456

M3 - Conference abstract in journal

SN - 0923-7534

VL - 32

SP - S889-S889

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 5

M1 - 1071P

T2 - ESMO Congress 2021

Y2 - 16 September 2021 through 21 September 2021

ER -